Jul. 21 at 3:03 PM
🚨
$INBS : Today's FDA Progress Update 🇺🇸
Today's news: Intelligent Bio Solutions announced it has successfully completed precision testing, another important step toward its FDA 510(k) submission and planned U.S. commercial launch.
🧪 Latest Update
🔹 Successfully completed precision testing, adding another key validation study to its FDA 510(k) submission.
🔹 The submission package now includes Precision, Method Comparison, Cut off, and Interference studies.
🔹 More than 1,600 tests were completed across 3 production runs and 3 independent testing sites, demonstrating consistent performance.
🔹 Targeting the U.S. drug screening market, estimated at over
$5.8B today and projected to surpass
$11.2B by 2034, with its fingerprint-based drug testing technology.
🔹 Results are available in under 10 minutes, with sample collection taking only seconds and no blood, urine, or saliva required.
Communicated Disclaimer: https://stockresearchtoday.com/inbs/
Sector Peers:
$CODX $FLGT $DGX $LH